S10 Ep47: Miller Discusses the Use of Selinexor in TP53 Wild-Type Advanced Endometrial Cancer

from OncLive® On Air · host OncLive® On Air

Dr Miller discusses findings from the SIENDO trial of selinexor maintenance therapy in patients with TP53 wild-type advanced endometrial cancer.

Episode metadata supplied by the publisher feed · Published Jul 25, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

S10 Ep47: Miller Discusses the Use of Selinexor in TP53 Wild-Type Advanced Endometrial Cancer

0:00 11:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 11 minutes long.

This episode was published on July 25, 2024.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!